Lapinskas, Tomas
Zieschang, Victoria
Erley, Jennifer
Stoiber, Lukas
Schnackenburg, Bernhard
Stehning, Christian
Gebker, Rolf
Patel, Amit R.
Kawaji, Keigo
Steen, Henning
Zaliunas, Remigijus
Backhaus, Sören J.
Schuster, Andreas
Makowski, Marcus
Giusca, Sorin
Korosoglou, Grigorious
Pieske, Burkert
Kelle, Sebastian http://orcid.org/0000-0001-8105-6599
Funding for this research was provided by:
DZHK (German Centre for Cardiovascular Research) and by the BMBF (None)
Philips
Myocardial Solutions (None)
Article History
Received: 12 August 2018
Accepted: 21 February 2019
First Online: 5 March 2019
Ethics approval and consent to participate
: The study conforms to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Ethics Committee of the Charité–Universitätsmedizin Berlin. All participants gave their written informed consent to participate to the study.
: Not applicable.
: All authors have read BioMed Central’s guidance on competing interests. SK owns stock options of Myocardial Solutions. BS and CS are employees of Philips Healthcare. TL, SK, AS, EPK and BP received support from the DZHK (German Centre for Cardiovascular Research). All other authors declare that they have no financial and non-financial competing interest to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.